APO Research
Talk to an analyst

APO RESEARCH · REPORT

Essential Hypertension Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Essential Hypertension Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchEssential Hypertension Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Essential Hypertension Drugs Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Essential Hypertension Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Essential Hypertension Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Essential Hypertension Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Essential Hypertension Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Essential Hypertension Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Essential Hypertension Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Essential Hypertension Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Essential Hypertension Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Essential Hypertension Drugs include Chengdu Easton Biopharmaceuticals, Shanghai Shyndec Pharmaceutical, Sanofi, Qingdao Huanghai Pharmaceutical, Novartis, Merck, Jiangsu Jibeier Pharmaceutical, Pfizer and CR Double-Crane, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Essential Hypertension Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Essential Hypertension Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Essential Hypertension Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Essential Hypertension Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Essential Hypertension Drugs Segment by Company

Chengdu Easton Biopharmaceuticals

Shanghai Shyndec Pharmaceutical

Sanofi

Qingdao Huanghai Pharmaceutical

Novartis

Merck

Jiangsu Jibeier Pharmaceutical

Pfizer

CR Double-Crane

Huahai Pharmaceutical

Tianjin Pharmaceutical Da Ren Tang Group

Boehringer Ingelheim

Bayer

AstraZeneca

Lupin Pharmaceuticals

Essential Hypertension Drugs Segment by Type

ACE Inhibitors

Beta Blockers

Calcium Channel Blockers

Diuretics

Angiotensin II Receptor Blockers

Others

Essential Hypertension Drugs Segment by Application

Hospital

Clinic

Others

Essential Hypertension Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Essential Hypertension Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Essential Hypertension Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Essential Hypertension Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Essential Hypertension Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Essential Hypertension Drugs industry.

Chapter 3: Detailed analysis of Essential Hypertension Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Essential Hypertension Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Essential Hypertension Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of ACE Inhibitors Table 3. Key Players of Beta Blockers Table 4. Key Players of Calcium Channel Blockers Table 3. Key Players of Diuretics Table 4. Key Players of Angiotensin II Receptor Blockers Table 5. Key Players of Others Table 6. Global Essential Hypertension Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Hospital Table 8. Key Players of Clinic Table 9. Key Players of Others Table 10. Global Essential Hypertension Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Essential Hypertension Drugs Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Essential Hypertension Drugs Market Share by Region (2021-2026) Table 13. Global Essential Hypertension Drugs Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Essential Hypertension Drugs Market Share by Region (2027-2032) Table 15. Essential Hypertension Drugs Industry Trends Table 16. Essential Hypertension Drugs Industry Drivers Table 17. Essential Hypertension Drugs Industry Opportunities and Challenges Table 18. Essential Hypertension Drugs Industry Restraints Table 19. Global Essential Hypertension Drugs Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Essential Hypertension Drugs Revenue Market Share by Company (2021-2026) Table 21. Global Essential Hypertension Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Essential Hypertension Drugs Key Company Head Office and Area Served Table 23. Global Essential Hypertension Drugs Company, Product Type & Application Table 24. Global Essential Hypertension Drugs Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Essential Hypertension Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Essential Hypertension Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Essential Hypertension Drugs Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Essential Hypertension Drugs Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Essential Hypertension Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Essential Hypertension Drugs Revenue Market Share by Type (2027-2032) Table 32. Global Essential Hypertension Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Essential Hypertension Drugs Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Essential Hypertension Drugs Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Essential Hypertension Drugs Revenue Market Share by Application (2021-2026) Table 36. Global Essential Hypertension Drugs Revenue Market Share by Application (2027-2032) Table 37. Chengdu Easton Biopharmaceuticals Company Information Table 38. Chengdu Easton Biopharmaceuticals Business Overview Table 39. Chengdu Easton Biopharmaceuticals Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Chengdu Easton Biopharmaceuticals Essential Hypertension Drugs Product Portfolio Table 41. Chengdu Easton Biopharmaceuticals Recent Development Table 42. Shanghai Shyndec Pharmaceutical Company Information Table 43. Shanghai Shyndec Pharmaceutical Business Overview Table 44. Shanghai Shyndec Pharmaceutical Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Shanghai Shyndec Pharmaceutical Essential Hypertension Drugs Product Portfolio Table 46. Shanghai Shyndec Pharmaceutical Recent Development Table 47. Sanofi Company Information Table 48. Sanofi Business Overview Table 49. Sanofi Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Sanofi Essential Hypertension Drugs Product Portfolio Table 51. Sanofi Recent Development Table 52. Qingdao Huanghai Pharmaceutical Company Information Table 53. Qingdao Huanghai Pharmaceutical Business Overview Table 54. Qingdao Huanghai Pharmaceutical Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Qingdao Huanghai Pharmaceutical Essential Hypertension Drugs Product Portfolio Table 56. Qingdao Huanghai Pharmaceutical Recent Development Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Novartis Essential Hypertension Drugs Product Portfolio Table 61. Novartis Recent Development Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Merck Essential Hypertension Drugs Product Portfolio Table 66. Merck Recent Development Table 67. Jiangsu Jibeier Pharmaceutical Company Information Table 68. Jiangsu Jibeier Pharmaceutical Business Overview Table 69. Jiangsu Jibeier Pharmaceutical Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Jiangsu Jibeier Pharmaceutical Essential Hypertension Drugs Product Portfolio Table 71. Jiangsu Jibeier Pharmaceutical Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Pfizer Essential Hypertension Drugs Product Portfolio Table 76. Pfizer Recent Development Table 77. CR Double-Crane Company Information Table 78. CR Double-Crane Business Overview Table 79. CR Double-Crane Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. CR Double-Crane Essential Hypertension Drugs Product Portfolio Table 81. CR Double-Crane Recent Development Table 82. Huahai Pharmaceutical Company Information Table 83. Huahai Pharmaceutical Business Overview Table 84. Huahai Pharmaceutical Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Huahai Pharmaceutical Essential Hypertension Drugs Product Portfolio Table 86. Huahai Pharmaceutical Recent Development Table 87. Tianjin Pharmaceutical Da Ren Tang Group Company Information Table 88. Tianjin Pharmaceutical Da Ren Tang Group Business Overview Table 89. Tianjin Pharmaceutical Da Ren Tang Group Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Tianjin Pharmaceutical Da Ren Tang Group Essential Hypertension Drugs Product Portfolio Table 91. Tianjin Pharmaceutical Da Ren Tang Group Recent Development Table 92. Boehringer Ingelheim Company Information Table 93. Boehringer Ingelheim Business Overview Table 94. Boehringer Ingelheim Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Boehringer Ingelheim Essential Hypertension Drugs Product Portfolio Table 96. Boehringer Ingelheim Recent Development Table 97. Bayer Company Information Table 98. Bayer Business Overview Table 99. Bayer Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 100. Bayer Essential Hypertension Drugs Product Portfolio Table 101. Bayer Recent Development Table 102. AstraZeneca Company Information Table 103. AstraZeneca Business Overview Table 104. AstraZeneca Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 105. AstraZeneca Essential Hypertension Drugs Product Portfolio Table 106. AstraZeneca Recent Development Table 107. Lupin Pharmaceuticals Company Information Table 108. Lupin Pharmaceuticals Business Overview Table 109. Lupin Pharmaceuticals Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 110. Lupin Pharmaceuticals Essential Hypertension Drugs Product Portfolio Table 111. Lupin Pharmaceuticals Recent Development Table 112. North America Essential Hypertension Drugs Market Size by Type (2021-2026) & (US$ Million) Table 113. North America Essential Hypertension Drugs Market Size by Type (2027-2032) & (US$ Million) Table 114. North America Essential Hypertension Drugs Market Size by Application (2021-2026) & (US$ Million) Table 115. North America Essential Hypertension Drugs Market Size by Application (2027-2032) & (US$ Million) Table 116. North America Essential Hypertension Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Essential Hypertension Drugs Market Size by Country (2021-2026) Table 118. North America Essential Hypertension Drugs Market Size by Country (2027-2032) Table 119. Europe Essential Hypertension Drugs Market Size by Type (2021-2026) & (US$ Million) Table 120. Europe Essential Hypertension Drugs Market Size by Type (2027-2032) & (US$ Million) Table 121. Europe Essential Hypertension Drugs Market Size by Application (2021-2026) & (US$ Million) Table 122. Europe Essential Hypertension Drugs Market Size by Application (2027-2032) & (US$ Million) Table 123. Europe Essential Hypertension Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Essential Hypertension Drugs Market Size by Country (2021-2026) Table 125. Europe Essential Hypertension Drugs Market Size by Country (2027-2032) Table 126. China Essential Hypertension Drugs Market Size by Type (2021-2026) & (US$ Million) Table 127. China Essential Hypertension Drugs Market Size by Type (2027-2032) & (US$ Million) Table 128. China Essential Hypertension Drugs Market Size by Application (2021-2026) & (US$ Million) Table 129. China Essential Hypertension Drugs Market Size by Application (2027-2032) & (US$ Million) Table 130. Asia Essential Hypertension Drugs Market Size by Type (2021-2026) & (US$ Million) Table 131. Asia Essential Hypertension Drugs Market Size by Type (2027-2032) & (US$ Million) Table 132. Asia Essential Hypertension Drugs Market Size by Application (2021-2026) & (US$ Million) Table 133. Asia Essential Hypertension Drugs Market Size by Application (2027-2032) & (US$ Million) Table 134. Asia Essential Hypertension Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia Essential Hypertension Drugs Market Size by Country (2021-2026) Table 136. Asia Essential Hypertension Drugs Market Size by Country (2027-2032) Table 137. South America, Middle East & Africa Essential Hypertension Drugs Market Size by Type (2021-2026) & (US$ Million) Table 138. South America, Middle East & Africa Essential Hypertension Drugs Market Size by Type (2027-2032) & (US$ Million) Table 139. South America, Middle East & Africa Essential Hypertension Drugs Market Size by Application (2021-2026) & (US$ Million) Table 140. South America, Middle East & Africa Essential Hypertension Drugs Market Size by Application (2027-2032) & (US$ Million) Table 141. South America, Middle East & Africa Essential Hypertension Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. South America, Middle East & Africa Essential Hypertension Drugs Market Size by Country (2021-2026) Table 143. South America, Middle East & Africa Essential Hypertension Drugs Market Size by Country (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Essential Hypertension Drugs Product Image Figure 2. Global Essential Hypertension Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Essential Hypertension Drugs Market Share by Type: 2025 VS 2032 Figure 4. ACE Inhibitors Image Figure 5. Beta Blockers Image Figure 6. Calcium Channel Blockers Image Figure 7. Diuretics Image Figure 8. Angiotensin II Receptor Blockers Image Figure 9. Others Image Figure 10. Global Essential Hypertension Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Essential Hypertension Drugs Market Share by Application: 2025 VS 2032 Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Others Image Figure 15. Global Essential Hypertension Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 17. Global Essential Hypertension Drugs Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global Essential Hypertension Drugs Market Share by Players in 2025 Figure 20. Global Top 5 and 10 Essential Hypertension Drugs Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Essential Hypertension Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Essential Hypertension Drugs Revenue Market Share by Type (2021-2032) Figure 24. Global Essential Hypertension Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Essential Hypertension Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 27. North America Essential Hypertension Drugs Market Share by Type (2021-2032) Figure 28. North America Essential Hypertension Drugs Market Share by Application (2021-2032) Figure 29. North America Essential Hypertension Drugs Market Share by Country (2021-2032) Figure 30. United States Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Canada Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 32. Mexico Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 33. Europe Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 34. Europe Essential Hypertension Drugs Market Share by Type (2021-2032) Figure 35. Europe Essential Hypertension Drugs Market Share by Application (2021-2032) Figure 36. Europe Essential Hypertension Drugs Market Share by Country (2021-2032) Figure 37. Germany Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 38. France Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 39. U.K. Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Italy Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 41. Russia Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 43. China Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 44. China Essential Hypertension Drugs Market Share by Type (2021-2032) Figure 45. China Essential Hypertension Drugs Market Share by Application (2021-2032) Figure 46. Asia Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 47. Asia Essential Hypertension Drugs Market Share by Type (2021-2032) Figure 48. Asia Essential Hypertension Drugs Market Share by Application (2021-2032) Figure 49. Asia Essential Hypertension Drugs Market Share by Country (2021-2032) Figure 50. Japan Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 51. South Korea Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 54. India Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 55. Australia Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Essential Hypertension Drugs Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa Essential Hypertension Drugs Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa Essential Hypertension Drugs Market Share by Country (2021-2032) Figure 60. Brazil Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 61. South Africa Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 63. Turkey Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Argentina Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 65. UAE Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 66. Egypt Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 67. Chile Essential Hypertension Drugs Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • ACE Inhibitors
  • Beta Blockers
  • Calcium Channel Blockers
  • Diuretics
  • Angiotensin II Receptor Blockers
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Chengdu Easton Biopharmaceuticals
  • Shanghai Shyndec Pharmaceutical
  • Sanofi
  • Qingdao Huanghai Pharmaceutical
  • Novartis
  • Merck
  • Jiangsu Jibeier Pharmaceutical
  • Pfizer
  • CR Double-Crane
  • Huahai Pharmaceutical
  • Tianjin Pharmaceutical Da Ren Tang Group
  • Boehringer Ingelheim
  • Bayer
  • AstraZeneca
  • Lupin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Essential Hypertension Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 ACE Inhibitors
  5. 1.2.3 Beta Blockers
  6. 1.2.4 Calcium Channel Blockers
  7. 1.2.5 Diuretics
  8. 1.2.6 Angiotensin II Receptor Blockers
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Essential Hypertension Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Hospital
  13. 1.3.3 Clinic
  14. 1.3.4 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global Essential Hypertension Drugs Growth Trends by Region
  17. 1.5.1 Global Essential Hypertension Drugs Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 Essential Hypertension Drugs Market Size by Region (2021-2026)
  19. 1.5.3 Essential Hypertension Drugs Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global Essential Hypertension Drugs Market Dynamics
  1. 2.1 Essential Hypertension Drugs Industry Trends
  2. 2.2 Essential Hypertension Drugs Industry Drivers
  3. 2.3 Essential Hypertension Drugs Industry Opportunities and Challenges
  4. 2.4 Essential Hypertension Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Essential Hypertension Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Essential Hypertension Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Essential Hypertension Drugs Key Company Head office and Area Served
  4. 3.4 Global Essential Hypertension Drugs Company, Product Type & Application
  5. 3.5 Global Essential Hypertension Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Essential Hypertension Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Essential Hypertension Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Essential Hypertension Drugs Tier 1, Tier 2, and Tier 3
4 Essential Hypertension Drugs Market by Type
  1. 4.1 Global Essential Hypertension Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Essential Hypertension Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Essential Hypertension Drugs Market Size Share by Type (2021-2032)
5 Essential Hypertension Drugs Market by Application
  1. 5.1 Global Essential Hypertension Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Essential Hypertension Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Essential Hypertension Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Chengdu Easton Biopharmaceuticals
  2. 6.1.1 Chengdu Easton Biopharmaceuticals Company Information
  3. 6.1.2 Chengdu Easton Biopharmaceuticals Business Overview
  4. 6.1.3 Chengdu Easton Biopharmaceuticals Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Chengdu Easton Biopharmaceuticals Essential Hypertension Drugs Product Portfolio
  6. 6.1.5 Chengdu Easton Biopharmaceuticals Recent Developments
  7. 6.2 Shanghai Shyndec Pharmaceutical
  8. 6.2.1 Shanghai Shyndec Pharmaceutical Company Information
  9. 6.2.2 Shanghai Shyndec Pharmaceutical Business Overview
  10. 6.2.3 Shanghai Shyndec Pharmaceutical Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Shanghai Shyndec Pharmaceutical Essential Hypertension Drugs Product Portfolio
  12. 6.2.5 Shanghai Shyndec Pharmaceutical Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sanofi Essential Hypertension Drugs Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Qingdao Huanghai Pharmaceutical
  20. 6.4.1 Qingdao Huanghai Pharmaceutical Company Information
  21. 6.4.2 Qingdao Huanghai Pharmaceutical Business Overview
  22. 6.4.3 Qingdao Huanghai Pharmaceutical Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Qingdao Huanghai Pharmaceutical Essential Hypertension Drugs Product Portfolio
  24. 6.4.5 Qingdao Huanghai Pharmaceutical Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novartis Essential Hypertension Drugs Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merck Essential Hypertension Drugs Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 Jiangsu Jibeier Pharmaceutical
  38. 6.7.1 Jiangsu Jibeier Pharmaceutical Company Information
  39. 6.7.2 Jiangsu Jibeier Pharmaceutical Business Overview
  40. 6.7.3 Jiangsu Jibeier Pharmaceutical Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Jiangsu Jibeier Pharmaceutical Essential Hypertension Drugs Product Portfolio
  42. 6.7.5 Jiangsu Jibeier Pharmaceutical Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Pfizer Essential Hypertension Drugs Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 CR Double-Crane
  50. 6.9.1 CR Double-Crane Company Information
  51. 6.9.2 CR Double-Crane Business Overview
  52. 6.9.3 CR Double-Crane Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 CR Double-Crane Essential Hypertension Drugs Product Portfolio
  54. 6.9.5 CR Double-Crane Recent Developments
  55. 6.10 Huahai Pharmaceutical
  56. 6.10.1 Huahai Pharmaceutical Company Information
  57. 6.10.2 Huahai Pharmaceutical Business Overview
  58. 6.10.3 Huahai Pharmaceutical Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Huahai Pharmaceutical Essential Hypertension Drugs Product Portfolio
  60. 6.10.5 Huahai Pharmaceutical Recent Developments
  61. 6.11 Tianjin Pharmaceutical Da Ren Tang Group
  62. 6.11.1 Tianjin Pharmaceutical Da Ren Tang Group Company Information
  63. 6.11.2 Tianjin Pharmaceutical Da Ren Tang Group Business Overview
  64. 6.11.3 Tianjin Pharmaceutical Da Ren Tang Group Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Tianjin Pharmaceutical Da Ren Tang Group Essential Hypertension Drugs Product Portfolio
  66. 6.11.5 Tianjin Pharmaceutical Da Ren Tang Group Recent Developments
  67. 6.12 Boehringer Ingelheim
  68. 6.12.1 Boehringer Ingelheim Company Information
  69. 6.12.2 Boehringer Ingelheim Business Overview
  70. 6.12.3 Boehringer Ingelheim Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Boehringer Ingelheim Essential Hypertension Drugs Product Portfolio
  72. 6.12.5 Boehringer Ingelheim Recent Developments
  73. 6.13 Bayer
  74. 6.13.1 Bayer Company Information
  75. 6.13.2 Bayer Business Overview
  76. 6.13.3 Bayer Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Bayer Essential Hypertension Drugs Product Portfolio
  78. 6.13.5 Bayer Recent Developments
  79. 6.14 AstraZeneca
  80. 6.14.1 AstraZeneca Company Information
  81. 6.14.2 AstraZeneca Business Overview
  82. 6.14.3 AstraZeneca Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 AstraZeneca Essential Hypertension Drugs Product Portfolio
  84. 6.14.5 AstraZeneca Recent Developments
  85. 6.15 Lupin Pharmaceuticals
  86. 6.15.1 Lupin Pharmaceuticals Company Information
  87. 6.15.2 Lupin Pharmaceuticals Business Overview
  88. 6.15.3 Lupin Pharmaceuticals Essential Hypertension Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Lupin Pharmaceuticals Essential Hypertension Drugs Product Portfolio
  90. 6.15.5 Lupin Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Essential Hypertension Drugs Market Size (2021-2032)
  2. 7.2 North America Essential Hypertension Drugs Market Size by Type
  3. 7.2.1 North America Essential Hypertension Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Essential Hypertension Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Essential Hypertension Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Essential Hypertension Drugs Market Size by Application
  7. 7.3.1 North America Essential Hypertension Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Essential Hypertension Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Essential Hypertension Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Essential Hypertension Drugs Market Size by Country
  11. 7.4.1 North America Essential Hypertension Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Essential Hypertension Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Essential Hypertension Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Essential Hypertension Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Essential Hypertension Drugs Market Size (2021-2032)
  2. 8.2 Europe Essential Hypertension Drugs Market Size by Type
  3. 8.2.1 Europe Essential Hypertension Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Essential Hypertension Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Essential Hypertension Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Essential Hypertension Drugs Market Size by Application
  7. 8.3.1 Europe Essential Hypertension Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Essential Hypertension Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Essential Hypertension Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Essential Hypertension Drugs Market Size by Country
  11. 8.4.1 Europe Essential Hypertension Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Essential Hypertension Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Essential Hypertension Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Essential Hypertension Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Essential Hypertension Drugs Market Size (2021-2032)
  2. 9.2 China Essential Hypertension Drugs Market Size by Type
  3. 9.2.1 China Essential Hypertension Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Essential Hypertension Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Essential Hypertension Drugs Market Share by Type (2021-2032)
  6. 9.3 China Essential Hypertension Drugs Market Size by Application
  7. 9.3.1 China Essential Hypertension Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Essential Hypertension Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Essential Hypertension Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Essential Hypertension Drugs Market Size (2021-2032)
  2. 10.2 Asia Essential Hypertension Drugs Market Size by Type
  3. 10.2.1 Asia Essential Hypertension Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Essential Hypertension Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Essential Hypertension Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Essential Hypertension Drugs Market Size by Application
  7. 10.3.1 Asia Essential Hypertension Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Essential Hypertension Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Essential Hypertension Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Essential Hypertension Drugs Market Size by Country
  11. 10.4.1 Asia Essential Hypertension Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Essential Hypertension Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Essential Hypertension Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Essential Hypertension Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Essential Hypertension Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Essential Hypertension Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Essential Hypertension Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Essential Hypertension Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Essential Hypertension Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Essential Hypertension Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Essential Hypertension Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Essential Hypertension Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Essential Hypertension Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Essential Hypertension Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Essential Hypertension Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Essential Hypertension Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Essential Hypertension Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Essential Hypertension Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst